Antimony-containing Substances Group

Information sheet

These substances were identified for action under the Chemicals Management Plan (CMP).

**Summary of publications**
Substance group	CAS RN	Common name	DSL name	Public comments received on the draft screening assessment	Final screening assessment	Conclusion on section 64 criteria	Follow-up activities
Antimony-containing Substance Group	1314-60-9	Antimony pentoxide	Antimony oxide (Sb₂O₅)	HTML	HTML	Does not meet	None planned at this time
	1327-33-9^a	Antimony oxide	Antimony oxide
	1345-04-6	Antimony sulfide	Antimony sulfide (Sb₂S₃)
	10025-91-9	Antimony trichloride	Stibine, trichloro-
	15432-85-6	Sodium antimonate	Antimonate (SbO₃^1-), sodium
	15874-48-3	NA	Phosphorodithioic acid, O,O-dipropyl ester, antimony(3+) salt
	15890-25-2	Antimony diamyldithiocarbamate	Antimony, tris(dipentylcarbamodithioato-S,S')-, (OC-6-11)-
	15991-76-1	NA	Antimony, tris[bis(2-ethylhexyl)carbamodithioato-S,S']-, (OC-6-11)-
	28300-74-5	Antimony potassium tartrate (APT)	Antimonate(2-), bis[µ-[2,3-di(hydroxy-κO)butanedioato(4-)-κO¹:κO⁴]]di-, dipotassium, trihydrate, stereoisomer
	29638-69-5	Potassium antimonate	Antimonate (Sb₂O₇^4-), tetrapotassium
	33908-66-6	Sodium hexahydroxoantimonate	Antimonate (Sb(OH)₆^1-), sodium, (OC-6-11)-

**Timelines**
Date	Activity
July 11, 2020	Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol 154, No. 28.
September 15, 2018	Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 37.